Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
T-Therapeutics Ltd
T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge, focused on developing TCR-based therapeutics for cancer and autoimmune diseases. Utilizing…
T-Therapeutics Ltd
T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge, focused on developing TCR-based therapeutics for cancer and autoimmune diseases. Utilizing…
TL;DR
Headquarters: Granta Park, Cambridge, United Kingdom
Focus: TCR-based therapeutics for oncology and autoimmune disease
Platform: Proprietary OpTiMus® transgenic discovery platform
Founded: 2022
Recent financing: Series A; additional equity injection announced Nov 13, 2025
Company Overview
Problem Domain
Improving targeted T cell engagement for treatment of cancer and autoimmune diseases
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
$59,000,000
Series A announced in Nov 2023 with a syndicate including Sofinnova Partners, Cambridge Innovation Capital, Cambridge Enterprise, F-Prime, Sanofi Ventures and Digitalis Ventures.
$32,000,000
Additional equity injection announced Nov 13, 2025 adding Tencent and Business Growth Fund to the investor base.
Investor Signal
“Company backed by a syndicate including Sofinnova Partners, Cambridge Innovation Capital, Cambridge Enterprise, Digitalis Ventures, F-Prime, Sanofi Ventures, Tencent, Business Growth Fund and University of Cambridge Enterprise”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
3,800+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |